Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.

Saved in:
Bibliographic Details
Title: Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
Authors: Devillier R; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France., Raffoux E; Adult Haematology Department, Saint Louis Hospital, Paris, France., Rey J; Haematology Department, Institut Paoli Calmettes, Marseille, France., Lengline E; Adult Haematology Department, Saint Louis Hospital, Paris, France., Ronchetti AM; Adult Haematology Department, Saint Louis Hospital, Paris, France., Sebert M; Senior Haematology Department, Saint Louis Hospital, Paris, France., Boissel N; Adolescents and Young Adults Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France., Robin M; Allo Stem Cell Transplantation Department, Saint Louis Hospital, Paris, France., Vey N; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France., Kiladjian JJ; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.; Centre d'Investigation Clinique (CIC), Saint Louis Hospital, Paris, France., Dombret H; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France., Cluzeau T; Adult Haematology Department, Saint Louis Hospital, Paris, France. cluzeau.thomas@gmail.com.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France. cluzeau.thomas@gmail.com.; INSERM U1065, Centre mediterraneen de Medecine Moleculaire, Nice, France. cluzeau.thomas@gmail.com.
Source: British journal of haematology [Br J Haematol] 2016 Feb; Vol. 172 (4), pp. 628-30. Date of Electronic Publication: 2015 Jun 10.
Publication Type: Letter; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26061174
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Devillier+R%22">Devillier R</searchLink>; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Raffoux+E%22">Raffoux E</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rey+J%22">Rey J</searchLink>; Haematology Department, Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Lengline+E%22">Lengline E</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ronchetti+AM%22">Ronchetti AM</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sebert+M%22">Sebert M</searchLink>; Senior Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boissel+N%22">Boissel N</searchLink>; Adolescents and Young Adults Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.<br /><searchLink fieldCode="AU" term="%22Robin+M%22">Robin M</searchLink>; Allo Stem Cell Transplantation Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vey+N%22">Vey N</searchLink>; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.; Centre d'Investigation Clinique (CIC), Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dombret+H%22">Dombret H</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cluzeau+T%22">Cluzeau T</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France. cluzeau.thomas@gmail.com.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France. cluzeau.thomas@gmail.com.; INSERM U1065, Centre mediterraneen de Medecine Moleculaire, Nice, France. cluzeau.thomas@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2016 Feb; Vol. 172 (4), pp. 628-30. <i>Date of Electronic Publication: </i>2015 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26061174
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.13516
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 628
    Titles:
      – TitleFull: Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Devillier R
      – PersonEntity:
          Name:
            NameFull: Raffoux E
      – PersonEntity:
          Name:
            NameFull: Rey J
      – PersonEntity:
          Name:
            NameFull: Lengline E
      – PersonEntity:
          Name:
            NameFull: Ronchetti AM
      – PersonEntity:
          Name:
            NameFull: Sebert M
      – PersonEntity:
          Name:
            NameFull: Boissel N
      – PersonEntity:
          Name:
            NameFull: Robin M
      – PersonEntity:
          Name:
            NameFull: Vey N
      – PersonEntity:
          Name:
            NameFull: Kiladjian JJ
      – PersonEntity:
          Name:
            NameFull: Dombret H
      – PersonEntity:
          Name:
            NameFull: Cluzeau T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2016 Feb
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 172
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1